BNET Industries
Quidel Corp. (QDEL) is in the Pharma Industry
Latest News and Analysis
Market Commentary on Quidel Corp.
M2 PRESSWIRE-19 June 2007-Biotech News: Market Commentary on Quidel CorpC1994-2007 M2 COMMUNICATIONS LTD RDATE:19062007 Market Commentary on Quidel Corp (NASDAQ:QDEL) Quidel Corporation develops, manufactures, and markets point-of-care POC diagnostic solutions for infectious diseases and reproductive health primarily in...
Additional Resources
Quidel Announces Promotion of John Tamerius, Ph.D. to Senior Vice President, Clinical/Regulatory Affairs
SAN DIEGO -- Quidel Corporation (NASDAQ: QDEL), a leading provider of point-of-care rapid diagnostic tests, announced today that John D. Tamerius, Ph.D., currently vice president, clinical/regulatory affairs, has been promoted to senior vice president, clinical/regulatory affairs, effective November 10, 2008. "It is a pleasure to recognize John's expertise...
Quidel Reports Third Quarter 2008 Results
Earnings Per Share Increased 114 Percent on a 16 Percent Increase in Revenues SAN DIEGO -- Quidel Corporation (NASDAQ:QDEL), a leader in point-of-care rapid diagnostic tests, today announced financial results for the quarter ended September 30, 2008. Third Quarter & Year-to-Date 2008 Highlights: *...
Quidel Corporation Secures New $120 Million Credit Facility
SAN DIEGO -- Quidel Corporation (NASDAQ:QDEL), a leading provider of rapid point-of-care POC diagnostic tests, today announced that it entered into a new $120 million, five-year senior secured revolving credit facility with a group of four banks. Banc of America Securities, LLC was the sole arranger of the credit facility....
Quidel to Hold 2008 Third Quarter Conference Call on October 22, 2008
SAN DIEGO -- Quidel Corporation (NASDAQ:QDEL), a leading provider of rapid point-of-care POC diagnostic tests, will release 2008 third quarter financial results after market close on Wednesday, October 22, 2008. Following the release of the results, Caren L. Mason, president and chief executive officer, and John M. Radak,...
Quidel Influenza Test Selected for FluSTAR® Surveillance Program
QuickVue([R]) Test to Be Exclusive for 2008/09 Influenza Season SAN DIEGO -- Quidel Corporation (NASDAQ:QDEL), a leading provider of rapid point-of-care POC diagnostic tests, announced today that the QuickVue brand Influenza A+B test is the rapid flu test selected by Roche for use in over 400 physician offices...
Quidel to Present at the UBS 2008 Global Life Sciences Conference
SAN DIEGO -- Quidel Corporation (NASDAQ:QDEL), a leading provider of rapid point-of-care POC diagnostic tests, today announced that it will present at the UBS 2008 Global Life Sciences Conference to be held at the Grand Hyatt Hotel in New York on September 22-25, 2008. Caren Mason, President and...
Quidel Reports Second Quarter 2008 Results
Year-to-Date Net Income Increased 159% on a 20% Increase in Revenues SAN DIEGO -- Conference call information, first U.S. dial-in number should read: 1-800-561-2601 (sted (888) 561-2601). The corrected release reads: QUIDEL REPORTS SECOND QUARTER 2008 RESULTS Year-to-Date Net Income Increased 159%...
Quidel to Hold 2008 Second Quarter Conference Call on July 23, 2008
SAN DIEGO -- Quidel Corporation (NASDAQ:QDEL), a leading provider of rapid point-of-care POC diagnostic tests, will release 2008 second quarter financial results after market close on Wednesday, July 23, 2008. Following the release of the results, Caren L. Mason, president and chief executive officer, and John M. Radak,...
Quidel and Prodesse Announce Flu and RSV Molecular Partnership
SAN DIEGO -- Quidel Corporation (NASDAQ:QDEL), a leading provider of rapid point-of-care POC diagnostic tests, and Prodesse, Inc., a biotechnology company focused on developing molecular diagnostic reagents for a variety of infectious diseases, announced today an agreement between the two companies to jointly promote Prodesse's ProFlu+[TM] multiplex molecular diagnostic test...
Rapid aid in diagnosis
The QuickVue Respratory syncytial virus RSV test has been granted CLIA-waived status. This dipstick immunoassay allows for the rapid, qualitative detection of RSV antigen directly from nasopharyngeal swab or nasopharyngeal aspirate specimens for symptomatic pediatric patients (18 and younger). [ILLUSTRATION OMITTED] Quidel Visit www.rsleads.com/805ml-157...
Quidel Reports First Quarter 2008 Results
Earnings Per Share Increased 86 Percent to $0.26 on a 20 Percent Increase in Revenues SAN DIEGO -- Quidel Corporation (NASDAQ: QDEL), a leader in point-of-care rapid diagnostic tests, today announced financial results for the three months ended March 31, 2008. Recent Highlights: *...
Quidel to Hold 2008 First Quarter Conference Call on April 23, 2008
SAN DIEGO -- Quidel Corporation (NASDAQ: QDEL), a leading provider of rapid point-of-care POC diagnostic tests, will release 2008 first quarter financial results after market close on Wednesday, April 23, 2008. Following the release of the results, Caren L. Mason, president and chief executive officer, and John M....
Quidel Corporation and Susie's Cause Partner in Colorectal Cancer Awareness Event
SAN DIEGO -- Quidel Corporation (NASDAQ: QDEL), a leading provider of rapid point-of-care diagnostic tests, announced today that it is participating at an educational program and special event at "Gunther von Hagens' Body Worlds 2 & The Brain - Our Three Pound Gem" exhibit at the Maryland Science Center in...
Urgent news alert: Arthritic Pain Relief, Diabetes Awareness, Point of Care Diagnostic Test FDA Approval of CLIA Waiver & Pharmaceutical Conference Dates Stock News for You.
M2 PRESSWIRE-29 February 2008-Businessnetwire.us: Urgent news alert: Arthritic Pain Relief, Diabetes Awareness, Point of Care Diagnostic Test FDA Approval of CLIA Waiver & Pharmaceutical Conference Dates Stock News for YouC1994-2008 M2 COMMUNICATIONS LTD RDATE:29022008 New York, NY -- HealthSonix,...
Quidel Reports Fourth Quarter and Full Year 2007 Results
For the Year, Operating Income Increased 41 Percent on an 11 Percent Increase in Revenues SAN DIEGO -- Quidel Corporation (NASDAQ: QDEL), a leader in point-of-care rapid diagnostic tests, today announced financial results for the three months and year ended December 31, 2007. Full Year 2007...
BellwetherReport.com Analyst Review for QDEL, BPHX, SHOO and KALU
BellwetherReport.com is the leading onlinefinancial newsletter for investors seeking top independent and unbiasedresearch on NYSE, NASDAQ, AMEX, TSX, TSX-Venture and US Small-Cap listedcompanies. Investors seeking unbiased research on the companies mentionedare highly encouraged to sign up to www.bellwetherreport.com for a free 90day subscription. Today we have set up...
Quidel to Hold 2007 Fourth Quarter and Year-End Financial Results Conference Call on February 21, 2008
SAN DIEGO -- Quidel Corporation (NASDAQ: QDEL), a leading provider of rapid point-of-care POC diagnostic tests, will release 2007 fourth quarter and year-end financial results after market close on Thursday, February 21, 2008. Following the release of the results, Caren L. Mason, president and chief executive officer, and...
Quidel and bioMerieux Announce a Global Strategic Alliance in Rapid Diagnostics
SAN DIEGO & MARCY L'ETOILE, France -- Quidel Corporation (NASDAQ: QDEL) and bioMerieux (Euronext: BIM) have agreed to form a long-term global alliance in the area of rapid clinical diagnostics for the point-of-care. bioMerieux will become Quidel's primary distributor for its QuickVue([R]) rapid diagnostic tests outside the United States and...
Director index
Ackerman, F. Duane, Home Depot Inc. Adkins, Rodney, Pitney Bowes Inc. Bailey, Robert L., Micron Technology Inc. Bartz, Carol, Intel Corp. Beck, Julie A., Hilb Rogal & Hobbs Co. Beinecke, Candace K., Vornado Realty Trust Benson, Craig, Sycamore...
- Next »
- page 1 of 1
- « Previous
Sort byClose
Industry Transcripts by Seeking Alpha
-
Indevus Pharmaceuticals, Inc. F4Q08 (Qtr End 09/30/08) Earnings Call Transcript
on Nov 25, 2008about IDEV
-
Noven Pharmaceuticals, Inc. Q3 2008 Earnings Call Transcript
on Nov 24, 2008about NOVN
-
XenoPort, Inc. Q3 2008 Earnings Call Transcript
on Nov 24, 2008about XNPT
-
Repligen Corporation F2Q09 (Qtr End 09/30/08) Earnings Call Transcript
on Nov 24, 2008about RGEN
-
Omrix Biopharmaceuticals, Inc. Q3 2008 Earnings Call Transcript
on Nov 24, 2008about OMRI
Quidel Corp. Company Info
Contact Information
10165 McKellar Court
San Diego, CA
858 552-1100